Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation
Clinical trial NCT01707290 · COMPLETED
Trial details
- NCT number
- NCT01707290
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2016-04-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.